bf/NASDAQ:ARWR_icon.jpeg

NASDAQ:ARWR

Arrowhead Pharmaceuticals, Inc.

  • Stock

USD

Last Close

39.60

06/11 22:30

Market Cap

3.33B

Beta: 1.01

Volume Today

1.19M

Avg: 1.11M

PE Ratio

−16.68

PFCF: −12.05

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '15
Sep '16
Sep '17
Sep '18
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23
Sep '24
Sep '25
average inventory
644.96K
-
1.08M
67.24%
1.07M
1.03%
2.29M
114.78%
3.78M
65.05%
4.31M
13.79%
-8.63M
300.30%
-10.81M
25.28%
average payables
3.81M
-
8.63M
126.83%
8.15M
5.53%
3.44M
57.80%
5.23M
51.92%
7.24M
38.47%
8.14M
12.48%
6.16M
24.32%
19.37M
214.27%
23.63M
22.00%
14.53M
38.50%
average receivables
37.50K
-
71.40K
90.40%
197.59K
176.74%
494.37K
150.20%
753.52K
52.42%
5.55M
636.59%
5.83M
5.08%
705K
87.91%
3.41M
-
book value per share
1.92
-
1.57
18.50%
1.10
29.62%
1.15
3.95%
2.61
127.52%
4.58
75.93%
3.94
14.05%
1.01
74.49%
2.54
152.90%
1.60
37.25%
5.23
227.58%
capex per share
-0.03
-
-0.06
84.04%
-0.11
69.46%
-0.02
84.14%
-0.13
652.46%
-0.12
7.20%
-0.23
91.44%
-0.50
120.37%
-1.66
230.72%
1.18
171.34%
0.17
85.65%
capex to depreciation
-0.84
-
-1.18
40.38%
-1.69
42.57%
-0.30
82.08%
-2.70
793.89%
-2.01
25.60%
-2.85
41.74%
-5.06
77.66%
-14.15
179.34%
7.61
153.78%
0.95
87.55%
capex to operating cash flow
0.03
-
0.06
99.78%
0.33
452.05%
0.03
90.90%
-0.07
330.45%
0.13
280.65%
-0.14
209.85%
0.39
381.67%
1.15
196.23%
-0.31
126.61%
0.13
141.30%
capex to revenue
-5.16
-
-24.38
372.61%
-0.25
98.97%
-0.09
65.08%
-0.07
19.25%
-0.14
91.04%
-0.17
25.47%
-0.22
27.32%
-0.73
238.35%
39.84
5,526.53%
0.03
99.93%
cash per share
1.72
-
1.40
18.78%
0.89
36.51%
0.92
3.07%
2.76
201.22%
3.13
13.64%
3.55
13.18%
3.57
0.71%
3.78
5.90%
5.68
50.35%
5.84
2.78%
days of inventory on hand
days payables outstanding
days sales outstanding
172.90
-
0.79
99.54%
7.40
839.52%
1.43
80.68%
3.51
145.29%
27.07
671.61%
2.12
92.18%
3.00
-
debt to assets
0.01
-
0.02
271.18%
0.02
14.45%
0.02
14.47%
0.03
59.64%
0.04
21.65%
0.04
11.08%
0.12
227.75%
0.15
27.61%
0.10
31.55%
0.08
21.91%
debt to equity
0.01
-
0.03
314.64%
0.03
9.03%
0.02
22.00%
0.05
95.99%
0.05
3.77%
0.06
36.50%
0.77
1,132.11%
0.42
44.87%
0.63
49.11%
0.24
62.23%
dividend yield
earnings yield
-0.28
-
-0.18
34.56%
-0.11
41.00%
-0.03
68.46%
0.03
175.83%
-0.02
175.86%
-0.02
11.55%
-0.05
132.93%
-0.07
41.28%
-0.26
261.04%
-0.00
99.86%
enterprise value
249.93M
-
366.09M
46.48%
297.68M
18.69%
1.58B
430.40%
2.42B
53.47%
4.21B
73.93%
6.32B
49.90%
3.46B
45.27%
2.87B
16.92%
2.33B
18.72%
4.64B
98.55%
enterprise value over ebitda
-2.59
-
-4.94
90.86%
-8.97
81.46%
-30.56
240.77%
36.92
220.83%
-48.32
230.88%
-44.88
7.12%
-19.37
56.84%
-15.27
21.19%
-4.16
72.76%
47.14
1,233.65%
ev to operating cash flow
-3.80
-
-5.68
49.39%
-12.43
118.84%
-33.43
168.88%
14.00
141.88%
-44.18
415.50%
36.90
183.51%
-25.40
168.84%
-18.67
26.51%
-5.04
72.98%
25.82
611.83%
ev to sales
654.26
-
2.31K
253.39%
9.48
99.59%
97.81
932.00%
14.36
85.32%
47.90
233.66%
45.69
4.62%
14.22
68.88%
11.93
16.06%
657.53
5,410.28%
5.59
99.15%
free cash flow per share
-1.18
-
-1.12
5.20%
-0.43
61.46%
-0.58
34.91%
1.72
394.99%
-1.07
162.12%
1.42
233.55%
-1.79
225.90%
-3.10
72.85%
-5.05
62.89%
1.17
123.25%
free cash flow yield
-0.20
-
-0.15
25.71%
-0.10
34.58%
-0.03
69.59%
0.06
301.09%
-0.02
140.65%
0.02
192.11%
-0.05
337.81%
-0.12
112.60%
-0.26
125.96%
0.03
113.06%
graham net net
1.33
-
0.87
34.68%
0.58
32.96%
0.73
25.61%
1.65
126.34%
2.56
54.78%
0.74
71.22%
-2.08
382.75%
-0.70
66.34%
-2.24
219.19%
0.75
133.53%
graham number
8.32
-
6.87
17.50%
3.40
50.54%
4.10
20.61%
6.52
59.09%
9.31
42.80%
10.97
17.90%
6.15
43.92%
10.49
70.44%
13.20
25.90%
income quality
0.71
-
0.79
10.31%
0.70
11.68%
0.87
24.55%
2.55
193.51%
1.13
55.68%
-1.22
207.75%
0.77
163.45%
0.74
4.66%
0.76
3.24%
5.96
685.40%
intangibles to total assets
0.19
-
0.17
7.86%
0.20
13.77%
0.17
14.54%
0.05
70.99%
0.03
39.72%
0.02
34.57%
0.02
10.15%
0.01
22.46%
0.01
43.96%
0.00
34.07%
interest coverage
-0.13
-
-0.31
133.65%
-0.09
71.02%
-0.05
40.14%
0.01
116.49%
-0.01
215.26%
-24.35
240,145.38%
-35.47
45.64%
-11.19
68.46%
-18.58
66.09%
-1.10
94.08%
interest debt per share
12.73
-
4.40
65.44%
5.65
28.50%
12.56
122.30%
74.25
491.00%
91.46
23.17%
0.31
99.67%
0.82
169.16%
1.25
52.23%
1.25
0.05%
0.16
86.82%
inventory turnover
invested capital
0.01
-
0.03
314.64%
0.03
9.03%
0.02
22.00%
0.05
95.99%
0.05
3.77%
0.06
36.50%
0.77
1,132.11%
0.42
44.87%
1.03B
243,175,122,227.67%
1.19B
15.14%
market cap
330.38M
-
448.72M
35.82%
319.98M
28.69%
1.61B
402.12%
2.64B
64.62%
4.34B
63.98%
6.48B
49.34%
3.48B
46.20%
2.87B
17.68%
2.32B
19.11%
4.61B
98.83%
net current asset value
80.22M
-
57.35M
28.51%
44.75M
21.97%
62.40M
39.45%
159.44M
155.51%
261.65M
64.11%
83.27M
68.17%
-209.58M
351.69%
-367.50M
75.35%
-253.27M
31.08%
264.25M
204.33%
net debt to ebitda
0.83
-
1.12
33.83%
0.67
39.77%
0.54
19.90%
-3.38
727.95%
1.40
141.54%
1.13
19.60%
0.15
86.88%
-0.02
115.36%
-0.03
14.97%
0.23
982.45%
net income per share
-1.60
-
-1.34
16.49%
-0.47
65.24%
-0.65
39.93%
0.72
211.24%
-0.84
215.91%
-1.36
61.73%
-1.67
23.31%
-1.92
14.86%
-5.00
160.27%
-0.01
99.76%
operating cash flow per share
-1.15
-
-1.06
7.88%
-0.32
69.30%
-0.56
74.29%
1.84
426.52%
-0.95
151.37%
1.65
274.27%
-1.29
178.24%
-1.44
11.64%
-3.86
168.04%
1.34
134.74%
payables turnover
receivables turnover
2.11
-
463.26
21,843.99%
49.31
89.36%
255.22
417.61%
104.05
59.23%
13.48
87.04%
172.50
1,179.25%
121.55
-
research and ddevelopement to revenue
150.29
-
261.82
74.21%
1.01
99.61%
3.28
225.21%
0.48
85.37%
1.46
205.03%
1.49
1.88%
1.22
18.08%
1.47
20.03%
142.46
9,610.05%
0.73
99.49%
return on tangible assets
-0.86
-
-0.77
9.91%
-0.41
46.63%
-0.59
42.53%
0.20
134.83%
-0.17
181.62%
-0.20
21.29%
-0.26
28.35%
-0.27
4.71%
-0.53
94.99%
-0.00
99.78%
revenue per share
0.01
-
0.00
61.06%
0.43
16,287.80%
0.19
54.59%
1.80
831.81%
0.87
51.42%
1.33
52.58%
2.31
73.08%
2.26
2.25%
0.03
98.69%
6.20
20,817.87%
roe
-0.83
-
-0.86
2.46%
-0.42
50.62%
-0.57
34.61%
0.28
148.89%
-0.18
165.89%
-0.34
88.16%
-1.67
383.47%
-0.76
54.58%
-3.23
327.32%
-0.00
99.89%
roic
-0.86
-
-0.83
3.23%
-0.44
47.00%
-0.57
29.36%
0.24
141.78%
-0.18
177.59%
-0.32
75.33%
-0.68
109.18%
-0.41
38.90%
-1.98
377.11%
-0.01
99.66%
sales general and administrative to revenue
90.89
-
258.94
184.91%
1.02
99.61%
1.18
16.11%
0.16
86.71%
0.59
277.62%
0.59
1.43%
0.51
12.64%
0.38
24.85%
27.81
7,134.40%
0.15
99.46%
shareholders equity per share
1.92
-
1.57
18.50%
1.10
29.62%
1.15
3.95%
2.61
127.52%
4.58
75.93%
3.94
14.05%
1.01
74.49%
2.54
152.90%
1.55
39.09%
3.48
125.06%
stock based compensation to revenue
26.79
-
73.24
173.40%
0.25
99.66%
0.52
108.45%
0.07
85.98%
0.49
571.50%
0.55
12.46%
0.50
10.36%
0.32
34.70%
20.83
6,318.22%
0.08
99.63%
tangible asset value
84.80M
-
72.86M
14.08%
60.40M
17.10%
76.48M
26.61%
226.97M
196.79%
446.42M
96.68%
395.16M
11.48%
94.00M
76.21%
276.90M
194.58%
182.50M
34.09%
692.04M
279.20%
tangible book value per share
1.48
-
1.19
19.28%
0.82
31.51%
0.91
11.87%
2.42
164.47%
4.43
83.28%
3.81
14.06%
0.89
76.59%
2.59
190.93%
1.52
41.26%
5.17
239.58%
working capital
86.97M
-
64.86M
25.42%
49.20M
24.14%
66.40M
34.96%
168.18M
153.26%
281.69M
67.50%
238.06M
15.49%
302.30M
26.98%
110.03M
63.60%
592.30M
438.33%
755.15M
27.49%

All numbers in USD (except ratios and percentages)